Stay updated on Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-18T01:29:17.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The record presents the completed KEYNOTE-826 Phase 3 study of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer, including its design, outcomes, locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-10T21:24:48.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer shows an updated ClinicalTrials.gov site revision, from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:46:02.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:47:17.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-06T21:51:29.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Access to the study record now results in a 403 Forbidden error page, replacing the expected content with an access-denied message.
    Difference
    19%
    Check dated 2026-09-22T23:23:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.